Framework for Equitable Allocation of COVID-19 Vaccine

Milestones :: Perspectives :: Research

Framework for Equitable Allocation of COVID-19 Vaccine
National Academies of Sciences, Engineering, and Medicine
Committee on Equitable Allocation of Vaccine for the Novel Coronavirus; Helene Gayle, William Foege, Lisa Brown, and Benjamin Kahn, Editors
October 2020
PDF: https://download.nap.edu/cart/download.cgi?record_id=25917
Description
In response to the coronavirus disease 2019 (COVID-19) pandemic and the societal disruption it has brought, national governments and the international community have invested billions of dollars and immense amounts of human resources to develop a safe and effective vaccine in an unprecedented time frame. Vaccination against this novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), offers the possibility of significantly reducing severe morbidity and mortality and transmission when deployed alongside other public health strategies and improved therapies.
Health equity is intertwined with the impact of COVID-19 and there are certain populations that are at increased risk of severe illness or death from COVID-19. In the United States and worldwide, the pandemic is having a disproportionate impact on people who are already disadvantaged by virtue of their race and ethnicity, age, health status, residence, occupation, socioeconomic condition, or other contributing factors.
Framework for Equitable Allocation of COVID-19 Vaccine offers an overarching framework for vaccine allocation to assist policy makers in the domestic and global health communities. Built on widely accepted foundational principles and recognizing the distinctive characteristics of COVID-19, this report’s recommendations address the commitments needed to implement equitable allocation policies for COVID-19 vaccine.